| |
|
|
|
|
|
|
|||
|
Blood, 15 December 2004, Vol. 104, No. 13, pp. 4054-4062. Prepublished online as a Blood First Edition Paper on August 17, 2004; DOI 10.1182/blood-2004-01-0386.
Submitted February 4, 2004
Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA * Corresponding author; email: hditzel{at}health.sdu.dk.
HIV-1-associated thrombocytopenia (HIV-1-ITP) is a common complication of HIV-1 infection, frequently caused by increased peripheral platelet destruction mediated by anti-platelet antibodies (Ab) and/or platelet-bound immune complexes. Little is known about the specificity of the anti-platelet Abs at a molecular level. Here, we used IgG phage display libraries generated from three HIV-1-ITP patients to isolate a large panel of human monoclonal anti-platelet Abs by selection on unfixed platelets. The platelet antigen recognized by all the cloned Abs was identified to be the talin head domain (talin-H), a cleavage product of talin, which can be generated by platelet activation or HIV-1 protease. Talin-H was found in HIV-1-ITP circulating immune complexes, and anti-talin Abs were detected in HIV-ITP sera, but not in controls. The cloned anti-talin-H IgGs were highly somatically-mutated, indicative of an antigen-driven, affinity-matured response. These findings suggest that talin-H Ab may be a marker of HIV-ITP elicited due to exposure of immunodominant epitopes on talin-H as a result of a disease-related process. Abs to talin-H and related ICs may contribute to HIV-1-ITP.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||